Penn Mutual Asset Management - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 975 filers reported holding BAXTER INTL INC in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Penn Mutual Asset Management ownership history of BAXTER INTL INC
ValueSharesWeighting
Q1 2024$337,646
+51.2%
7,900
+61.2%
0.72%
+258.7%
Q2 2023$223,2444,9000.20%
Other shareholders
BAXTER INTL INC shareholders Q2 2023
NameSharesValueWeighting ↓
Soditic Asset Management LLP 147,620$7,951,0009.91%
NUANCE INVESTMENTS, LLC 5,429,702$292,444,0006.51%
Endurant Capital Management LP 245,093$13,201,0004.30%
Veritas Asset Management LLP 8,589,401$462,625,0003.83%
GENERATION INVESTMENT MANAGEMENT LLP 11,876,040$639,644,0003.80%
Sivik Global Healthcare LLC 120,000$6,463,0003.59%
KINGDON CAPITAL MANAGEMENT, L.L.C. 480,500$25,880,0003.31%
Integral Health Asset Management, LLC 300,000$16,158,0003.14%
Boothe Investment Group, Inc. 89,078$4,798,0003.11%
Glenview Capital Management 2,257,019$121,563,0003.04%
View complete list of BAXTER INTL INC shareholders